PublikationslisteAlle Publikationen sind mit dem Entrez-Pubmed verlinkt. Dort finden Sie auch die vollständige Liste aller Publikationen. |
|
| Kasabov N, Schliebs R, Kojima H | |
| Probabilistic computational neurogenetic modeling: from cognitive systems to Alzheimer’s disease. | |
| IEEE Trans Autonom Mental Dev 3 (2011) 300-311. | |
| Zarazúa S, Bürger S, Delgado JM, Jimenez-Capdeville ME, Schliebs R | |
| Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of APP. | |
| Int J Dev Neurosci 29 (2011) 389-396. | |
| M. Hartlage-Rübsamen, A. Waniek, C. Jäger, U. Zeitschel, B. Koch, H. Cynis, S. Schilling, R. Schliebs, H.-U. Demuth, M. Morawski, S. Roßner | |
| Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Abeta deposits in hippocampus via distinct cellular mechanisms. | |
| Acta Neuropathol. 121 (2011) 705-719. | |
| Hawkes CA, Härtig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, Carare RO | |
| Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. | |
| Acta Neuropathol. 121 (2011) 431-443 | |
| Schliebs R, Arendt T | |
| The cholinergic system in aging and neuronal degeneration. | |
| Behav Brain Res. 221 (2011) 555-563. | |
| Ihunwo A.O., Schliebs R. | |
| Cell proliferation and total granule cell number in dentate gyrus of transgenic Tg2576 mouse | |
| Acta Neurobiol Exp (Wars) 70 (2010) 362-369. | |
| S. Bürger, Y. Yafai, M. Bigl, P. Wiedemann, R. Schliebs | |
| Effect of VEGF and its receptor antagonist SU-5416, an inhibitor of angiogenesis, on processing of the beta-amyloid precursor protein in primary neuronal cells derived from brain tissue of Tg2576 mice. | |
| Int J Dev Neurosci. 28 (2010) 597-604. | |
| F. Kara, N. Braakman, M.A. van Buchem, H.J. de Groot, R. Schliebs, A. Alia | |
| In vivo longitudinal monitoring of blood flow alterations in Tg2576 mouse model of Alzheimer’s disease. | |
| Proc. Int. Soc. Magn. Reson. Med. 18 (2010) 4273. | |
| R Schliebs | |
| Molecular mechanisms of cholinergic dysfunction in Alzheimer’s disease – cell culture and animal approches. In: Tópicos de Actuación en Neurobilogía: Biología molecular del desarollo, neurodegeneración y medicina genómica (Eds., Daniel Ortuño Sahagún, Carlos Beas Zarate, Juan Armendáriz, Mercè Pallàs Lliberia, Antoni Camins) | |
| Universidad de Guadalajara, 2010, pp. 129-146. (ISBN 978-970-764-867-8) | |
| C.K. Donat, R. Bauer, T. Kayser, B. Walter, T. Kayser, R. Schliebs, W. Deuther-Conrad, K. Nieber, W. Härtig, P. Brust | |
| Effects of lateral fluid percussion injury on cholinergic markers in the newborn piglet brain. | |
| Int J Dev Neurosci 28 (2010) 31-38. | |
| S. Ebert, M. Goos, L. Rollwagen, D. Baake, W.-D. Zech, H. Esselmann, J. Wiltfang, M.L. Kramer, B. Mollenhauer, R. Schliebs, J. Gerber, R. Nau | |
| Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases. | |
| J Neurosci. Res. 88 (2010) 1124-1136. | |
| K. Plaschke, J. Kopitz, M. Siegelin, R. Schliebs, M. Salko-Petricic, P. Riederer, S. Hoyer | |
| Insulin-resistant brain state after intracerebroventricular streptozotocin injection deteriorates Alzheimer-like changes in tg2576 APP-overexpressing mice. | |
| J. Alzheimer Dis. 19 (2010) 691-704. | |
| G. Glavan, R. Schliebs, M. Zivin | |
| Synaptotagmins in neurodegeneration. | |
| The Anatomical Record 292 (2009) 1849-1862. | |
| Beas Zarate C, Gudiño Cabrera G, Armendariz Boruranda J, Schliebs R | |
| Terapia génica en enfermedades neurodegenerativas. In: BIOLOGIA MOLECULAR: Fundamentos y aplicaciones (Eds., Carlos Beas Zarate, Daniel Ortuño Sahagún, Juan Armendariz-Borunda); | |
| McGraw Hill, Mexico City, 2009, pp. 130-142. (ISBN 13: 978-970-10-6921-9). | |
| N. Braakman, M. van Buchem, R. Schliebs, H.J.M. de Groot, A. Alia | |
| Recent advances in visualizing Alzheimer´s plaques by in vivo magnetic resonance imaging. | |
| Current Medical Imaging Reviews 5 (2009) 2-9. | |
| Bürger S, Noack M, Kirazov LP, Kirazov EP, Naydenov CL, Kouznetsova E, Yafai Y, Schliebs R | |
| Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain | |
| Int J Dev Neurosci 27 (2009) 517-523. | |
| Walther T, Albrecht D, Becker M, Schubert M, Kouznetsova E, Wiesner, B., Maul, B., Schliebs, R., Grecksch, G., Furkert, J., Sterner-Kock, A., Schultheiss, H.-P., Becker, A., Siems W.-E. | |
| Improved Learning and Memory in Aged Mice Deficient in Amyloid beta-Degrading Neutral Endopeptidase | |
| PLoS ONE 4(2): e4590. doi:10.1371/journal.pone.0004590 | |
| Sorger D, Scheunemann M, Vercouillie J, Großmann U, Fischer S, Hiller A, Wenzel B, Roghani A, Schliebs R, Steinbach J, Brust P, Sabri O. | |
| Neuroimaging of the vesicular acetylcholine transporter by a novel 4-[18F]Fluoro-benzoyl derivative of 7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazines. | |
| Nucl Med Biol 36 (2009) 17-27. | |
| Augustin S, Rimbach G, Augustin K, Schliebs R, Wolffram S, Cermak R. | |
| Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease. | |
| Arch Biochem Biophys 481 (2009) 177-182 | |
| Rivera-Cervantes MC, Flores-Soto ME, Chaparro-Huerta, Reyes-Gómez J, Feria-Velasco A, Schliebs R, Beas-Zárate C | |
| Changes in hippocampal NMDA-R subunit composition induced by exposure of neonatal rats to L-glutamate. | |
| Int J Devl. Neurosci 27 (2009) 197-204 | |
| Morawski M, Pavlica S, Seeger G, Grosche J, Kouznetsova E, Schliebs R, Brückner | |
| Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice. | |
| Neurobiol. Aging 2008, in press. [Epub ahead of print] | |
| Bigl K, Gaunitz F, Schmitt A, Rothemund S, Schliebs R, Münch G, Arendt T | |
| Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. | |
| J Neural Transm 115 (2009) 1545-1556 | |
| Baier M, Apelt J, Riemer C, Gültner S, Schwarz A, Bamme T, Burwinkel M, Schliebs R | |
| Prion infection of mice transgenic for human APPSwe: Increased accumulation of cortical fibrillar Abeta(1-42) and rapid scrapie disease development. | |
| Int J Dev Neurosci 26 (2008) 821-824. | |
| Fiedorowicz A, Figiel I, Zaremba M, Dzwonek K, Schliebs R, Oderfeld-Nowak B | |
| Trimethyltin–evoked apoptosis of murine hippocampal granule neurons is accompanied by the expression of interleukin-1beta and interleukin-1 receptor antagonist in the cells of ameboid phenotype, the majority of which are NG2-positive. | |
| Brain Res Bull 77 (2008) 19-26. | |
| Augustin S, Huebbe P, Matzner N, Augustin K, Schliebs R, Cermak R, Wolffram S, Rimbach G | |
| Ginkgo biloba extract and its flavonol and terpenelacton fractions do not affect beta-secretase mRNA and enzyme activity levels in cultured neurons and in laboratory mice. | |
| Planta Medica 74 (2008) 6-13. | |
| Joerchel S, Raap M, Bigl M, Eschrich K, Schliebs R | |
| Oligomeric beta-amyloid(1-42) induces the expression of Alzheimer disease-relevant proteins in cholinergic SN56.B5.G4 cells as revealed by proteomic analysis. | |
| Int. J Dev. Neurosci. 26 (2008) 301-308 | |
| Herrmann P, Druckrey-Fiskaaen C, Kouznetsova E, Heinitz K, Bigl M, Cotman SL, Schliebs R | |
| Developmental impairments of select neurotransmitter systems in brains of Cln3deltaex7/8-knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis. | |
| J. Neurosci. Res. 86 (2008) 1857-1870. | |
| Sorger D, Scheunemann M, Großmann U, Fischer S, Vercouille J, Hiller A, Wenzel B, Roghani A, Schliebs R, Brust P, Sabri O, Steinbach J | |
| A new 18F-labelled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter. | |
| Nucl. Med. Biol. 35 (2008) 185-195. | |
| Donat CK, Schuhmann MU, Voigt C, Nieber K, Schliebs R, Brust P: | |
| Alterations of aetylcholinesterase aivity after traumatic brain injury in rats. | |
| Brain Injury 21 (2007) 1031-1037. | |
| Scheunemann M, Sorger D, Kouznetsova E, Sabri O, Schliebs R, Wenzel B, Steinbach J | |
| Sequential ring-opening of trans-1,4-cyclohexadiene dioxide for an expedient modular approach to 6,7-disubstituted (+)-hexahydro-benzo[1,4]oxazin-3-ones. | |
| Tetrahedron Lett. 48 (2007) 5497-5501. | |
| Yun S-W, Kouznetsova E, Nitschke C; Heinitz K, Schliebs R, Gerlach M, Riederer P, Klein MA | |
| Beta-amyloid deposition and prion infection in adult primary brain cell long-term culture model. | |
| Biochem. Biophys. Res Commun. 360 (2007) 520-524. | |
| Ihunwo AO, Luth H-J, Schliebs R, Kayanja FIB | |
| Ultrastructural Features of Beta-Amyloid Plaques in Aged Transgenic Tg 2576 Mouse Brain with Alzheimer Plaque Pathology. | |
| Res. J. Med. Sci. 1 (2007) 55-61. | |
| Gil-Bea FJ, Aisa B, Schliebs R, Ramirez MJ. | |
| Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice. | |
| Behav Neurosci. 121 (2007) 340-344 | |
| Sorger D, Becker GA, Patt M, Schildan A, Grossmann U, Schliebs R, Seese A, Kendziorra K, Kluge M, Brust P, Mukhin AG, Sabri O. | |
| Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. | |
| Nucl Med Biol. 34 (2007) 331-342. | |
| Stahl T, Reimers C, Johne R, Schliebs R, Seeger J. | |
| Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice. | |
| Eur J Neurosci. 24 (2006) 1923-1934. | |
| Schliebs R, Arendt T. | |
| The significance of the cholinergic system in the brain during aging and in Alzheimer's disease | |
| J Neural Transm. 113 (2006) 1625-1644. | |
| Sorger D, Becker G, Hauber K, Schildan A, Patt M, Birkenmeier G, Otto A, Meyer P, Kluge M, Schliebs R, Sabri O | |
| Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]Fluoro-A-85380 to plasma proteins. | |
| Nucl Med Biol 33 (2006) 899-906 | |
| Schliebs R, Heidel K, Apelt J, Gniezdzinska M, Kirazov L, Szutowicz A. | |
| Interaction of interleukin-1beta with muscarinic acetylcholine receptor-mediated signaling cascade in cholinergically differentiated SH-SY5Y cells. | |
| Brain Res. 1122 (2006) 78-85. | |
| N. Braakman, J. Matysik, S.G. van Duinen, F. Verbeek, R. Schliebs, H.J.M.de Groot, A. Alia | |
| Longitudinal assessment of Alzheimer’s beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. | |
| J. Magn Reson Imaging 24 (2006) 530-536 | |
| M.E. Flores-Soto, M.E. Banuelos-Pineda, R. Schliebs, C. Beas-Zarate | |
| Neuronal damage and changes in the expression muscarinic acetylcholine receptor subtypes in the neonatal rat cerebral cortex upon exposure to sparteine, a quinolizidine alkaloid | |
| Int J Dev Neurosci 24 (2006) 401-410 | |
| K. Heinitz, M. Beck, R. Schliebs, J. R. Perez-Polo | |
| Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells | |
| J Neurochem. 98 (2006) 1930-1945. | |
| Züchner T, Schliebe N, Schliebs R | |
| Zinc uptake is mediated by M1 muscarinic acetylcholine receptors in differentiated SK-SH-SY5Y cells. | |
| Int. J. Devl. Neurosci. 24 (2006) 23-27. | |
| Schliebs R | |
| Neural signal transduction in health and disease - cytokines, mitochondrial dysfunction and transport processes. Editorial. | |
| Int J Dev Neurosci 24 (2006) 87-89. | |
| Kouznetsova E, Klingner M, Sorger D, Sabri O, Großmann U, Steinbach J, Scheunemann M, Schliebs R | |
| Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. | |
| Int J Dev Neurosci. 24 (2006) 187-193. | |
| Liskowsky W, Schliebs R | |
| Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein | |
| Int J Dev Neurosci. 24 (2006) 149-156. | |
| Wenzel B, Sorger D, Heinitz K, Scheunemann M, Schliebs R, Steinbach J, Sabri O | |
| Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter. | |
| Eur J Med Chem. 40 (2005) 1197-1205 | |
| Rossner S, Schulz I, Zeitschel U, Schliebs R, Bigl V, Demuth HU. | |
| Brain Prolyl Endopeptidase Expression in Aging, APP Transgenic Mice and Alzheimer's Disease. | |
| Neurochem Res. 30 (2005) 695-702. | |
| T. Züchner, R. Schliebs, J.R. Perez-Polo | |
| Downregulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer´s disease relevant genes and proteins. | |
| J. Neurochem. 95 (2005) 20-32 | |
| R. Schliebs | |
| Basal forebrain cholinergic dysfunction in Alzheimer´s disease – interrelationship with beta-amyloid, inflammation and neurotrophin signaling. | |
| Neurochem. Res. 30 (2005) 895-908. | |
| L. Kirazov, E. Kirazov, R. Schliebs | |
| L-Glutamate and phorbol ester stimulate the release of secretory amyloid precursor protein from rat cortical synaptosomes. | |
| Acta Biol. Hung. 56 (2005) 177-183 | |
| R. Schliebs | |
| Basal forebrain cholinergic lesion by 192IgG-saporin: a tool to assess the consequences of cortical cholinergic dysfunction in Alzheimer´s disease. | |
| In: Molecular Neurosurgery with Targeted Toxins (R.G. Wiley and D.A. Lappi, Eds.), The Humana Press Inc., Totowa, NJ, 2005, pp. 59-86. ISBN: 1-58829-199-5 | |
| Schliebs R | |
| Molecular mechanisms of neurodegeneration and neuroprotection - experimental approaches and the diseased brain. Editorial. | |
| Int J Devl Neurosci 22 (2004) 441-442 | |
| Apelt J, Bigl M, Wunderlich P, Schliebs R | |
| Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. | |
| Int J Devl Neurosci 22 (2004) 475-484 | |
| Zuchner T, Perez-Polo JR, Schliebs R | |
| Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling | |
| J Neurosci Res 77 (2004) 250-257 | |
| Scheunemann M, Sorger D, Wenzel B, Heinitz K, Schliebs R, Klingner M, Sabri O, Steinbach J | |
| Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site | |
| Bioorgan. Med. Chem. 12 (2004) 1459-1465 | |
| Blasko I, Beer R, Bigl M, Apelt J, Franz G, Rudzki D, Ransmayr G, Kampfl A, Schliebs R | |
| Experimental traumatic brain injury in rat stimulates the expression, production and activity of Alzheimer’s disease beta-secretase(BACE-1) | |
| J Neural Transm 111 (2004) 523-536. | |
| Klingner M, Apelt J, Kumar A, Sorger D, Sabri O, Steinbach J, Scheunemann M, Schliebs R. | |
| Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology. | |
| Int J Dev Neurosci 21 (2003) 357-369. | |
| Münch G, Apelt J, Kientsch-Engel R, Stahl P, Lüth HJ, Schliebs R | |
| Advanced glycation endproducts (AGEs) and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology | |
| J Neurochem 86 (2003) 283-289 | |
| Lüth HJ, Apelt J, Ihunwo A, Schliebs R | |
| Degeneration of beta-amyloid-associated cholinergic structures in transgenic APPsw mice | |
| Brain Res 977 (2003) 16-22 | |
| Apelt J, Ach K, Schliebs R | |
| Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques | |
| Neurosci Lett 339 (2003) 183-186. | |
| Hartlage-Rübsamen M, Zeitschel U, Apelt J, Gärtner U, Franke H, Stahl T, Günther A, Schliebs R, Penkowa M, Bigl V, Roßner S. | |
| Astrocytic expression of the Alzheimer’s disease beta-secretase (BACE1)is stimulus-dependent. | |
| Glia 41 (2003) 169-179. | |
| Bigl M, Apelt J, Eschrich K, Schliebs R | |
| Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology. | |
| J Neural Transm 110 (2003) 77-94. | |
| Otth C, Concha II, Arendt T, Stieler J, Schliebs R, Gonzalez-Billault C, Maccioni RB. | |
| AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. | |
| J. Alzheimers Dis. 4 (2002) 417-430. | |
| Zeitschel U, Schliebs R, Rossner S, Bigl V, Eschrich K, Bigl M. | |
| Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion. | |
| J Neurochem 83 (2002) 371-380. | |
| Apelt J, Kumar A, Schliebs R. | |
| Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein | |
| Brain Research 2002; 953:17-30. | |
| Hartig W, Bauer A, Brauer K, Grosche J, Hortobagyi T, Penke B, Schliebs R, Harkany T. | |
| Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions? | |
| Rev Neurosci. 2002;13(2):95-165 | |
| Loffler T, Lee SK, Noldner M, Chatterjee SS, Hoyer S, Schliebs R. | |
| Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain. | |
| J Neural Transm. 2001;108(12):1457-74. | |
| Kirazov E, Kirazov L, Bigl V, Schliebs R. | |
| Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. | |
| Int J Dev Neurosci 2001; 19:287-96 | |
| Rossner S, Apelt J, Schliebs R, Perez-Polo JR, Bigl V. | |
| Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. | |
| J Neurosci Res. 2001; 64:437-46. | |
| Loffler T, Al-Robaiy S, Bigl M, Eschrich K, Schliebs R. | |
| Expression of fructose-1,6-bisphosphatase mRNA isoforms in normal and basal forebrain cholinergic lesioned rat brain. | |
| Int J Dev Neurosci. 2001 Jun;19(3):279-85. | |
| Schliebs R | |
| Neuronal plasticity and degeneration. | |
| Int J Dev Neurosci. 2001 Jun;19(3):229-30. | |
| Rossner S, Mendla K, Schliebs R, Bigl V. | |
| Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo. | |
| Eur J Neurosci. 2001; 13:1644-1648. | |
| Hartlage-Rubsamen M, Apelt J, Schliebs R. | |
| Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology. | |
| Neurosci Lett. 200; 302:73-76. | |
| Hartlage-Rubsamen M, Schliebs R. | |
| Sequential upregulation of cell adhesion molecules in degenerating rat basal forebrain cholinergic neurons and in phagocytotic microglial cells. | |
| Brain Res 200; 897:20-26. | |
| Apelt J, Schliebs R. | |
| Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. | |
| Brain Res 2001; 894:21-30. | |
| Rossner S, Mehlhorn G, Schliebs R, Bigl V. | |
| Increased neuronal and glial expression of protein kinase C isoforms in neocortex of transgenic Tg2576 mice with amyloid pathology. | |
| Eur J Neurosci 2001; 13:269-278. | |
| Hartlage-Rubsamen M, Schliebs R. | |
| Rat basal forebrain cholinergic lesion affects neuronal nitric oxide synthase activity in hippocampal and neocortical target regions. | |
| Brain Res 2001; 889:155-164. | |
| Hoyer S, Lee SK, Loffler T, Schliebs R. | |
| Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? | |
| Ann N Y Acad Sci 2000; 920:256-258. | |
| Bigl M, Apelt J, Luschekina EA, Lange-Dohna C, Rossner S, Schliebs R. | |
| Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology. | |
| Neurosci Lett 2000; 292:107-110. | |
| Rossner S, Beck M, Stahl T, Mendla K, Schliebs R, Bigl V. | |
| Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation. | |
| Eur J Neurosci 2000; 12:3191-3200. | |
| Mehlhorn G, Hollborn M, Schliebs R. | |
| Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. | |
| Int J Dev Neurosci 2000; 18:423-431. | |
| Rossner S, Schliebs R, Bigl V. | |
| Intracerebroventricular infusion of CHO5, a rat monoclonal antibody directed against mouse low-affinity nerve growth factor receptor (p75NTR), specifically labels basal forebrain cholinergic neurons in mouse brain. | |
| Metab Brain Dis 2000; 15:17-27. | |
| Sorger D, Schliebs R, Kampfer I, Rossner S, Heinicke J, Dannenberg C, Georgi P. | |
| In vivo [125I]-iodobenzovesamicol binding reflects cortical cholinergic deficiency induced by specific immunolesion of rat basal forebrain cholinergic system. | |
| Nucl Med Biol 2000; 27:23-31. | |
| Reisner E, Noldner M, Rossner S, Chatterjee SS, Bigl V, Schliebs R. | |
| Acute effect of KA-672, a putative cognitive enhancer, on neurotransmitter receptor binding in mouse brain. | |
| Neurosci Lett 1999; 274:187-190. | |
| Apelt J, Mehlhorn G, Schliebs R. | |
| Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. | |
| J Neurosci Res 1999; 57:693-705. | |
| Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V. | |
| Regulated secretion of amyloid precursor protein by TrkA receptor stimulation in rat pheochromocytoma-12 cells is mitogen activated protein kinase sensitive. | |
| Neurosci Lett 1999; 271:97-100. | |
| Hartlage-Rubsamen M, Lemke R, Schliebs R. | |
| Interleukin-1beta, inducible nitric oxide synthase, and nuclear factor-kappaB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-gamma injection. | |
| J Neurosci Res 1999; 57:388-398. | |
| Lemke R, Hartlage-Rubsamen M, Schliebs R. | |
| Differential injury-dependent glial expression of interleukins-1 alpha, beta, and interleukin-6 in rat brain. | |
| Glia 1999; 27:75-87. | |
| Lemke R, Rossner S, Schliebs R. | |
| Leukemia inhibitory factor expression is not induced in activated microglia and reactive astrocytes in response to rat basal forebrain cholinergic lesion. | |
| Neurosci Lett 1999; 267:53-56. | |
| Sorger D, Kampfer I, Schliebs R, Rossner S, Dannenberg C, Knapp WH. | |
| Iodo-QNB cortical binding and brain perfusion: effects of a cholinergic basal forebrain lesion in the rat. | |
| Nucl Med Biol 1999; 26:9-16. | |
| Stahl T, Goldammer A, Luschekina E, Beck M, Schliebs R, Bigl V. | |
| Long-term basal forebrain cholinergic-rich grafts derived from trisomy 16 mice do not develop beta-amyloid pathology and neurodegeneration but demonstrate neuroinflammatory responses. | |
| Int J Dev Neurosci 1998; 16:763-775. | |
| Mehlhorn G, Loffler T, Apelt J, Rossner S, Urabe T, Hattori N, Nagamatsu S, Bigl V, Schliebs R. | |
| Glucose metabolism in cholinoceptive cortical rat brain regions after basal forebrain cholinergic lesion. | |
| Int J Dev Neurosci 1998; 16:675-690. | |
| Rossner S, Bakinde N, Zeitschel U, Schliebs R, Bigl V. | |
| Cerebrospinal fluid cholinesterases--markers for loss of cholinergic basal forebrain neurons? | |
| Int J Dev Neurosci 1998; 16:669-673. | |
| Schliebs R. | |
| Basal forebrain cholinergic dysfunction-experimental approaches and the diseased brain. | |
| Int J Dev Neurosci 1998; 16:591-593. | |
| Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V. | |
| Neurotrophin binding to the p75 neurotrophin receptor is necessary but not sufficient to mediate NGF-effects on APP secretion in PC-12 cells. | |
| J Neural Transm Suppl 1998; 54:279-285. | |